This CME activity is expired. For more CME activities, visit CMEInstitute.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders
Article Abstract
During the reproductive years, depression is common in women, and many face treatment decisions during pregnancy. Possible risks of untreated maternal depression include increased risk of relapse and postpartum depression, all the serious risks associated with the untreated disorder in nonpregnant women, and obstetrical complications. Data on teratogenic risks of antidepressant use are inconsistent, but these risks should be taken into consideration. Overall, treatment should be individually tailored, and nonpharmacologic options may be appropriate.
Vol 86 • 2025 • Number 3
Read the Current Issue
Original Research
Postpartum Distress in Women With and Without ADHD
Academic Highlights
Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Schizophrenia: A Consensus Panel Report
Academic Highlights
Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Bipolar Type I Disorder: A Consensus Panel Report
In Memoriam
In Memoriam: Terence A. Ketter, MD
Narrative Review
Idiopathic Hypersomnia: Recognition and Management in Psychiatric Practice
Original Research